Clinical Trial Update: Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557 [Phase 1]

View source ↗

Summary

This document reports a completed Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat doses o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2269557

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED